-
公开(公告)号:EP3738583A1
公开(公告)日:2020-11-18
申请号:EP19739175.8
申请日:2019-03-08
发明人: KANG, Il Mo , KIM, Dae Duk , PARK, Ju Hwan , ROH, Ki Min , LEE, Jang Ike , KIM, Jae Hwan , SEO, Sung Man , JUNG, Su Young
摘要: A drug and layered silicate composite is provided. The drug and layered silicate contains layered silicate powders; and a drug compound bound to between layers of the silicate powders, wherein the drug compound is present in an amorphous state in the composite. Using such a composite may significantly improve absorption and bioavailability of a sorafenib compound.
-
2.
公开(公告)号:EP4176903A1
公开(公告)日:2023-05-10
申请号:EP21832931.6
申请日:2021-07-01
发明人: KIM, Jae Hwan , KANG, Il Mo , KIM, Dae Duk , LEE, Jang Ik , KIM, Gyu Ho , BAEK, Min Jun , PARK, Chang Yun , ROH, Ki Min , SEO, Sung Man
IPC分类号: A61K47/54 , A61K47/52 , A61K31/554 , A61K31/496 , A61K31/337 , A61K31/4745 , A61K31/55 , A61K31/517 , A61K31/5513 , A61K31/519
摘要: According to one embodiment of the present invention, provided is a drug-clay mineral complex, in which the complex comprises a phospholipid, and the drug has an amine group.
-